Together, our study in APOE E4+ carriers and two previously published studies in AD donors consistently show downregulation of oligodendrocyte differentiation and myelination genes, such as PLP1 and OPALIN, and their corresponding GO terms17,19. The gene discussed is APOE; the disease is Alzheimer disease.